NCT05186025Active, not recruiting
Tyrosine Allergoid Paediatric and Adult Study
A Long-term, Prospective, Open, Multi-centre, Non-interventional Study to Evaluate the Effectiveness After Treatment With TA Bäume Top (Trees) and TA Gräser Top (Grass) Following a Perennial Posology in Children and Adults, as Well as Proofing the Non-inferiority of Children Compared to Adults
Source: ClinicalTrials.gov · Last updated 30 Jan 2026
Brief summary (registry, in English)
The primary objective of this 5-year study is to demonstrate non-inferiority of children compared to adults by exploring long-term effectiveness after treatment with TA Bäume (trees) and TA Gräser (grass) following a perennial posology.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 320 (actual)
- First submitted
- 20 Oct 2021
- Start date
- 6 Nov 2020
- Primary completion date
- Jun 2026
- Lead sponsor
- Allergy Therapeutics
- Diseases
- Asthma
- NCT number
- NCT05186025
What you commit to
- Study type: Observational
- Participants enrolled: 320
- From 6 Nov 2020 to the primary completion date, Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- If it´s intended to treat the patient with only a preseasonal therapy
Other illness
- History of allergen-specific immunotherapy (SIT) for trees or grass within the last 5 years
- A patient should also not be included in the presence of any of the conditions listed in the respective SmPC
Who the study is looking for
- Patients from 5 years of age who are treated with TA Gräser top or TA Bäume top due to rhinitis, conjunctivitis and/or mild to moderate bronchial asthma, which are caused by an IgE-mediated allergy to grass and rye pollen or birch, alder and hazel pollen according to the respective SmPC.
- Patients will only be included in this study after the decision on the treatment has been made.
Age in the registry: 5 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitätsklinikum Augsburg Coordinator of this site? Confirm its status | Augsburg | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.